ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Cardiovascular Disease

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

10,932Medicare Part D Prescriptions Filled, Including Refills

Rank: 34 out of 1019

$641K Total Retail Price of All Prescriptions

Rank: 44 out of 1019

534 Patients Receiving at Least One Drug in Part D
86%Patients 65 Years and Older
33% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Texas
Lower avg

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

12% of this provider’s 534 patients filled at least one prescription for a schedule three drug, compared to an average of 1%.

Risky Drugs to Seniors

1% of this provider’s 9,688 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 0%.

Brand Name Drugs

25% of this provider’s prescriptions were for brand-name drugs, compared to an average of 27%.

Prescription Price

$59 was the average price of a prescription from this provider, compared to $64 among peers.

Prescriptions per Patient

20 is the average number of prescriptions (including refills) per patient, compared to an average of 11.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Texas
FUROSEMIDE 541 509 1 6
POTASSIUM CHLORIDE 489 453 2 15
DIGOXIN 338 306 3 14
OMEPRAZOLE 282 243 4 41
SIMVASTATIN 259 234 5 5
LEVOTHYROXINE SODIUM 239 210 6 25
CARVEDILOL 214 187 7 3
LISINOPRIL 209 187 8 2
DILTIAZEM 24HR CD 209 200 8 48
PROPRANOLOL HCL 203 186 10 113
CLOPIDOGREL 186 161 11 7
VYTORIN 171 140 12 62
ZETIA 163 137 13 30
ENALAPRIL MALEATE 160 141 14 38
HYDROCODONE-ACETAMINOPHEN 159 97 S3 15 36
METOPROLOL TARTRATE 152 134 16 8
KLOR-CON M20 150 139 17 56
AMLODIPINE BESYLATE 138 132 18 4
METFORMIN HCL 138 115 18 42
VERAPAMIL ER 130 112 20 77
PLAVIX 128 121 21 11
WARFARIN SODIUM 128 123 21 9
CRESTOR 128 107 21 13
GABAPENTIN 121 107 24 66
AMIODARONE HCL 120 120 25 22
ATORVASTATIN CALCIUM 119 97 26 10
DOXAZOSIN MESYLATE 117 103 27 65
SERTRALINE HCL 115 104 28 94
LOVASTATIN 112 88 29 44
RANITIDINE HCL 102 102 30 104
TAMSULOSIN HCL 96 90 31 80
NEXIUM 92 73 32 52
PAROXETINE HCL 90 76 33 142
HYDROCHLOROTHIAZIDE 87 61 34 18
LOSARTAN POTASSIUM 86 79 35 17
LOSARTAN-HYDROCHLOROTHIAZIDE 86 71 35 31
FENOFIBRATE 82 77 37 58
DIOVAN 82 74 37 20
TRIAMTERENE-HCTZ 74 69 39 57
NIFEDICAL XL 72 69 40 86
ZOLPIDEM TARTRATE 72 64 40 55
NITROSTAT 72 65 40 27
DILTIAZEM ER 72 59 40 79
ALLOPURINOL 71 71 44 75
METOPROLOL SUCCINATE 66 63 45 1
SPIRONOLACTONE 66 58 45 23
TRAMADOL HCL 61 57 47 71
LISINOPRIL-HYDROCHLOROTHIAZIDE 61 56 47 28
CITALOPRAM HBR 61 59 47 90
KLOR-CON M10 59 54 50 174
TRILIPIX 59 58 50 70
METHYLPREDNISOLONE 58 52 52 138
GLIPIZIDE 56 51 53 119
INDAPAMIDE 55 55 54 180
AZITHROMYCIN 54 46 55 96
NITROGLYCERIN PATCH 53 53 56 59
NAMENDA 51 51 57 123
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Aug. 9, 2013.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.